Skip to main content
Pharming Group N.V. logo

Pharming Group N.V. — Investor Relations & Filings

Ticker · PHARM ISIN · NL0010391025 LEI · 724500DCJ9MPG74JEH91 AS Manufacturing
Open in API
Filings indexed 802 across all filing types
Latest filing 2006-01-03 Regulatory Filings
Country NL Netherlands
Listing AS PHARM

About Pharming Group N.V.

https://www.pharming.com/

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.

Recent filings

Filing Released Lang Actions
PHARMING ANNOUNCES ISSUE OF SHARES UNDER AGREEMENTS
Regulatory Filings
2006-01-03 English
PHARMING PRESENTS RHC1INH UPDATE AT INTERNATIONAL MEETINGS
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Pharming Group N.V. presented clinical results of recombinant human C1 inhibitor (rhC1INH) at several international meetings. It discusses clinical study results, safety profile, and background information about the disease and the company. There is no indication that this is a financial report, regulatory filing, or detailed investor presentation. The document is relatively short (3695 characters) and serves as a news announcement about clinical updates rather than a formal report or filing. It does not contain financial data, management changes, voting results, or legal proceedings. Therefore, it fits best as a Regulatory Filing (RNS) which is a general category for miscellaneous announcements that do not fit other specific categories.
2005-11-17 English
PHARMING PRESENTS RHC1INH UPDATE AT INTERNATIONAL MEETINGS
Regulatory Filings
2005-11-17 English
PHARMING ANNOUNCES RESULTS FOR FIRST NINE MONTHS 2005
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial report announcing Pharming Group N.V.'s financial results for the first nine months of 2005, including consolidated balance sheet, statement of income, and cash flow statement. It contains substantive financial data and analysis for a period shorter than a full fiscal year (nine months). The text includes detailed financial figures, operational highlights, product development updates, and corporate changes. It is not merely an announcement or a brief summary but a comprehensive interim financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2005
2005-11-03 English
PHARMING APPOINTS NEW HEAD OF FINANCE AND ADMINISTRATION-Company completes operations transition
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Head of Finance and Administration at Pharming Group N.V. It details management changes, specifically the replacement of the CFO and operational transitions. There is no financial data, no report attached or referenced as published, and no mention of regulatory filings or financial results. The content focuses on board/management changes rather than financial performance or other report types. Therefore, the document fits best under Board/Management Information (MANG). The document length is short (3056 characters), consistent with a management announcement rather than a full report.
2005-10-24 English
PHARMING APPOINTS NEW HEAD OF FINANCE AND ADMINISTRATION-Company completes operations transition
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Head of Finance and Administration at Pharming Group N.V. It details personnel changes in senior management positions, specifically the CFO role, and provides background on the company. There is no financial data, report, or regulatory filing referenced or attached. The content focuses on management changes rather than financial results, governance rules, or shareholder votes. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS.
2005-10-24 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.